Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Daily News

Asundexian’s Lack of Efficacy Sinks OCEANIC-AF

L.A. McKeown

November 20, 2023

News Daily News

Label for Impella RP Flex Catheters Recalled to Address Anticoagulant Confusion: FDA

Caitlin E. Cox

August 18, 2023

News Daily News

FDA: Class I Recall for Left-Sided Impella Pumps Due to TAVI Interaction

Caitlin E. Cox

July 27, 2023

News Daily News

Abiomed Recalls Certain Impella 5.5 Devices Due to Risk of Purge-Fluid Leaks

Caitlin E. Cox

June 05, 2023

News Conference News AHA 2021

Risk-Based EHR Alert Doesn’t Improve HF Care or Outcomes: REVEAL-HF

Michael O'Riordan

November 19, 2021

News Daily News

Papers Probe Temporal Link Between COVID-19 Vaccines and Myocarditis

Michael O'Riordan

June 17, 2021

News Features

Hydroxychloroquine: No Help, Clear Harm in COVID-19 RCT and Cohort Studies

Shelley Wood

May 20, 2020

News Daily News

Kawasaki Link to COVID-19 in Kids Probed as UK, New York Issue Alerts

Shelley Wood

May 06, 2020

News Conference News

ACC, EHRA Cancel 2020 Meetings Over COVID-19

Michael O'Riordan

March 09, 2020

News Daily News

FDA: Class I Recall for CentriMag Circulatory Support System Motor

Caitlin E. Cox

November 07, 2019

News Daily News

FDA Tallies Cases of Fournier Gangrene in Patients Taking SGLT2 Inhibitors

Michael O'Riordan

May 08, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2018

Shelley Wood

November 30, 2018

News Features

Catheter Kerfuffle: How Concerning Is Off-Label Use in Stroke Interventions?

Todd Neale

June 21, 2017

News Daily News

TCTMD’s Top 10 Most Popular Stories for April 2017

Shelley Wood

April 28, 2017

News Daily News

Under Surveillance: Ballooning Numbers, Better Survival, Lower-Risk Patients in Latest TVT Registry Data

L.A. McKeown

December 13, 2016

News Daily News

St. Jude Medical Warns of Rapid, Unexpected, and Potentially Lethal Battery Depletions With ICDs, CRT-Ds

Shelley Wood

October 11, 2016

News Daily News

FDA Declines to Approve Portola’s Reversal Agent for Factor Xa Inhibitors

Michael O'Riordan

August 18, 2016

News Daily News

Experimental FAAH Inhibitors Do Not Pose Safety Risk, FDA Concludes

Michael O'Riordan

August 12, 2016

Advertisement

Asundexian’s Lack of Efficacy Sinks OCEANIC-AF

Label for Impella RP Flex Catheters Recalled to Address Anticoagulant Confusion: FDA

FDA: Class I Recall for Left-Sided Impella Pumps Due to TAVI Interaction

Abiomed Recalls Certain Impella 5.5 Devices Due to Risk of Purge-Fluid Leaks

Risk-Based EHR Alert Doesn’t Improve HF Care or Outcomes: REVEAL-HF

Papers Probe Temporal Link Between COVID-19 Vaccines and Myocarditis

Hydroxychloroquine: No Help, Clear Harm in COVID-19 RCT and Cohort Studies

Kawasaki Link to COVID-19 in Kids Probed as UK, New York Issue Alerts

ACC, EHRA Cancel 2020 Meetings Over COVID-19

FDA: Class I Recall for CentriMag Circulatory Support System Motor

FDA Tallies Cases of Fournier Gangrene in Patients Taking SGLT2 Inhibitors

TCTMD’s Top 10 Most Popular Stories for November 2018

Catheter Kerfuffle: How Concerning Is Off-Label Use in Stroke Interventions?

TCTMD’s Top 10 Most Popular Stories for April 2017

Under Surveillance: Ballooning Numbers, Better Survival, Lower-Risk Patients in Latest TVT Registry Data

St. Jude Medical Warns of Rapid, Unexpected, and Potentially Lethal Battery Depletions With ICDs, CRT-Ds

FDA Declines to Approve Portola’s Reversal Agent for Factor Xa Inhibitors

Experimental FAAH Inhibitors Do Not Pose Safety Risk, FDA Concludes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content